Friday 6 November 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue: +4.29%
EPS: +2.17%
Free cash flow: +27.0%
Total debt: −18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%

Follow RVTY

Alert me

Market cap: $16.8B
P/E: 71.9×
Fwd P/E: 66.2×
Dividend yield: 0.19%
F-score: 6/9
Altman Z: 2.49
Beneish M: −2.45
Dividend safety: 80/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revvity Inc. (RVTY) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Revvity Inc. (RVTY) trades at a price to free cash flow of 28.2×. Over the past ten years it has ranged from 0.0× (December 2023) to 2,840× (January 2024); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RVTY/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Revvity Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RVTY/metrics/price-to-free-cash-flow">Revvity Inc. (RVTY) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	22.4×	(12.44%)
FY2024	25.5×	(99.09%)
FY2023	2,808×	9,192.01%
FY2022	30.2×	70.76%
FY2021	17.7×	(8.45%)
FY2020	19.3×	(49.22%)
FY2019	38.1×	12.13%
FY2018	33.9×	4.72%
FY2017	32.4×	89.95%
FY2016	17.1×	(26.69%)

Period	Price to free cash flow	Change
Sep 2026	28.6×	29.97%
Jun 2026	22.0×	11.34%
Mar 2026	19.7×	(11.74%)
Dec 2025	22.4×	8.81%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 2,840×

Ten-year median 24.7×

Current reading's percentile 64

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
ICLR ICON PLC compare	18.1×
DGX Quest Diagnostics Incorporated compare	20.3×
QGEN QIAGEN N.V. compare	23.8×
LH Labcorp Holdings Inc. compare	25.4×
MEDP Medpace Holdings, Inc. compare	26.6×
RVTY Revvity Inc.	28.2×
ILMN Illumina, Inc. compare	30.4×
CRL Charles River Laboratories International, Inc. compare	37.6×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Revvity Inc. (RVTY) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on RVTY

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on RVTY

Stockrow Weekly